test

Harold Schaaff

@Soleus Capital Management, L.p.

Latest period2024 - Q3ReportedManaged Assets$1.291BTotal holdings87
Assets growth rate13.9%Assets growth rate (2-Q avg)-0.97%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Soleus Capital Management, L.p.'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 87 positions.

Assets under management

The assets under management (AUM) of Soleus Capital Management, L.p. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.291B in assets, with a quarterly growth rate of 13.9% and a 2-quarter average growth rate of -0.97%. The portfolio is managed by Harold Schaaff, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
TNGXTango Therapeutics Inc
Recent Activity
Decreased -67.31%
0.21%
$2.642M
343,152 shares@ $7.7 avg price
INSMInsmed Inc
Recent Activity
Decreased -70.45%
0.18%
$2.21M
30,272 shares@ $73.0 avg price
VRDNViridian Therapeutics Inc
Recent Activity
Decreased -72.05%
0.17%
$2.161M
95,000 shares@ $22.75 avg price
GSKGsk Plc
Recent Activity
Decreased -90.96%
0.12%
$1.533M
37,500 shares@ $40.88 avg price
OLMAOlema Pharmaceuticals Inc
Recent Activity
Decreased -52.19%
0.1%
$1.236M
103,500 shares@ $11.94 avg price
IMVTImmunovant Inc
Recent Activity
Decreased -96.15%
0.03%
$275,920
9,678 shares@ $28.52 avg price